What is the generic name?

SATRALIZUMAB

What is the Trade Name for SATRALIZUMAB?

Enspryng

What are the Indications for SATRALIZUMAB?

• 1 INDICATIONS AND USAGE ENSPRYNG is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. ENSPRYNG is an interleukin-6 (IL-6) receptor antagonist indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. ( 1 )

References: https://open.fda.gov/